Breast Augmentation (Implants) | Breast Implant Removal, Replacement and Revision

Implants are not medically necessary devices, so removal without replacement can be appropriate when repeated complications, infection, severe tissue thinning or uncorrectable deformity are concerns. It is a joint decision because the breast may look smaller or less full afterward, sometimes resembling post-pregnancy changes. If a capsular contracture or significant rupture is found, the scar capsule may also be removed. If sagging or laxity remains, a breast lift may be added. Some women also choose removal when they no longer want implants, and the final plan should be agreed jointly with the surgeon. Removing one implant alone usually creates asymmetry and often leads to another operation, so bilateral removal is usually preferred when removal is indicated.

Implants are not medically necessary, and removal without replacement can be the safest option when complications or tissue thinning make keeping them risky. After explantation, your breast may look smaller or less full; a 2020 review noted loss of breast and muscle volume after longstanding implants. In one study, nearly 33% of patients who had explantation without replacement felt disappointed, and 13% felt mutilated. Implant removal without replacement is an alternative available before any reoperation and can minimize additional risks, costs, and potentially uncorrectable deformities; if implant size was based on tissue dimensions, the breast often returns to a form approximating pregnancy effects. If laxity or sagging remains, a lift may be considered; capsule problems may need capsulectomy.

An implant supports and projects breast tissue; once removed, that support disappears. If skin and breast tissue have stretched over time, they may not spring back, so the breast can look flatter above and lower on the chest. This is more likely after larger implants or longer wear. Many patients develop noticeable ptosis and loss of upper fullness after removal. Some then consider reshaping using their own tissue to restore contour, but suitability depends on your anatomy, skin quality and goals. Removal may be considered when breasts are ptotic, heavy or unaesthetic, but the final shape cannot be guaranteed. Dr. Purohit can explain options during consultation.

Implants push breast tissue forward and add volume; once removed, that support disappears, so the breast can lose upper fullness and the nipple may sit differently. One source notes the nipple drops about 2 cm with augmentation and tends to return higher after removal, while another notes many patients develop significant ptosis and upper-breast fullness loss after removal. Skin quality, original breast size, implant duration and whether a lift is combined all influence the result. Removal may be chosen for discomfort, size or shape concerns, and some patients can have a smaller, balanced breast created; one described option uses your own breast tissue to fill the space left after removal.

The operation is not one fixed procedure. The implant plane—under the breast tissue, under the chest muscle, or both—must be considered, and removal may be combined with capsule removal or reshaping depending on goals and findings. Evidence does not directly compare explantation with capsule removal versus explantation alone; strong prospective data show symptom improvement after explantation without capsule removal is statistically indistinguishable from partial or total capsule removal. Capsule removal carries a higher complication rate, and no published evidence shows harm from leaving a capsule after benign explantation. Capsular contaminants and silicone migration have not been shown to differentiate symptomatic patients or be reduced by capsule removal.

Unlike total capsulectomy, which removes the anterior and posterior capsule, en bloc resection removes the whole capsule with the implant still inside, plus a defined margin of healthy tissue and any associated masses. It is an oncologic procedure, not a routine explantation technique. Evidence supports it only for diagnosed BIA-ALCL, not for body-wide symptoms or worry about textured implants. Leaving the implant in the capsule helps maintain tension while dissection proceeds outside it. Removing healthy tissue increases surgical risk and can make an aesthetic result harder to achieve. Patients should be counseled extensively about these increased risks. The decision should follow the surgeon’s evaluation and a frank discussion of risks and benefits.

En bloc capsulectomy removes implant, capsule, masses and healthy tissue margin together. Evidence supports it only for diagnosed BIA-ALCL, not systemic illness complaints or textured implants with only future-risk concern. Without concern for breast implant-associated malignancy, removing healthy tissue around the capsule is unsupported and may increase surgical risk. Patient preference matters, but evidence-based selection and frank discussion of risks and aesthetic trade-offs remain essential. Total capsulectomy removes anterior and posterior capsule; it is more invasive, with higher bleeding and complication risk than partial capsulectomy or capsulotomy. Most subglandular implants allow easier total capsulectomy; submuscular placement or a thin, fragile capsule can make removal difficult, sometimes requiring strip capsulectomy or removal in sections.

The capsule is scar tissue that forms around an implant. Total capsulectomy removes the anterior and posterior capsule; if the capsule is thin or fragile, it may be removed piecemeal as strips, still called total capsulectomy when all capsule is removed. It may be appropriate for capsular contracture, especially subglandular implants, significant silicone granulomas, or grossly purulent infected pockets. It is not the same as en bloc resection, which removes capsule and implant with healthy tissue margins and is reserved for diagnosed BIA-ALCL. Complete removal can help remove silicone that bled into the capsule and allow tissue redraping, but if it would leave less than 5 mm soft tissue coverage, preserving capsule may be safer.

Capsulectomy is not automatic. Capsule care depends on implant type, pocket location and tissue quality, and your surgeon balances complete removal with safety. If the capsule has no disease, a simpler release may be preferred because it avoids extra surgical time and risk and preserves blood supply to the skin. When the capsule has disease, partial or total removal may help remove silicone that has leaked into it and allow better tissue settling, but if removal would leave less than 5 mm soft-tissue cover, the capsule may be left to protect coverage. En bloc removal is reserved for diagnosed BIA-ALCL, not routine removal.

A smaller implant may leave extra skin or a larger pocket, so the result depends on skin elasticity, pocket size and how much volume is removed. If the decrease is modest, exchange alone may be enough; if marked, skin reduction similar to mastopexy may be needed. Previously operated augmented breasts can make this more complex. Implant choice should be tissue-based, considering breast width, height, envelope characteristics and realistic expectations. The surgeon evaluates these factors during consultation. This is why a seemingly simple exchange can become a more involved revision. No outcome can be guaranteed. Pocket adjustment may also be required to support the smaller implant, and healing and final shape vary between patients.

Implant selection should be tissue-based, not only preference. A modestly larger implant may be exchanged when the skin envelope has adequate elasticity and thickness. If a larger implant cannot be placed without undue tension, a tissue expander may be used first, followed by staged implant exchange. Poor skin quality, such as after radiation, may need combined reconstruction with healthy tissue coverage. Larger implants also increase likelihood of additional operations, costs and permanent uncorrectable deformities; visible edges, rippling, additional sensation loss and tissue stretch may occur. Any reoperation increases risks and offers no assurance of better result. Breast augmentation is major surgery with potential risks, and the hoped-for result cannot be guaranteed.

Both implant types share a silicone shell; the difference is filler. Silicone gel usually feels softer and more natural, especially with thin breast tissue, while saline is more prone to visible or palpable wrinkling and can deflate if the shell leaks. Saline may suit patients with at least B-cup tissue and minimal droop, or those who prefer it. Saline implants can be placed through smaller incisions, and differential fill may help correct minor asymmetry. Under older FDA guidance, silicone was limited to specific situations, including replacement of prior implants, reconstruction, significant asymmetry or augmentation with lift. The final choice should follow discussion of risks, benefits and your anatomy.

Fat transfer moves your own fat from areas such as the abdomen, hips or flanks into the breast. It can restore volume after implant removal, correct asymmetry or add a natural cushion over implants, sometimes allowing a smaller implant. However, it often requires more than one session, gives a modest increase of about one to two cup sizes or 220 mL, and does not correct ptosis or tubular deformity without expanders. Baseline breast imaging may be prudent before lipo-augmentation. Fat survival depends on available space and blood supply, so results vary and realistic expectations matter. It can also be combined with augmentation, and your surgeon will assess donor fat and breast tissue.

Revision breast surgery is a broad term and may involve implants, lifts, reductions or reconstructions. Implant revision is common because implants are generally not lifetime devices, so further surgery may be needed later. Reasons include healing problems, infection, shape, symmetry, scars, or breast changes over time. All potential risks are more likely in secondary procedures, so careful planning and realistic expectations matter. It can range from minor scar or shape adjustments to fuller reshaping or resizing. Every presentation is unique, and the likelihood for further revision surgery is greater in secondary cases than in primary augmentation. A thoughtful approach to patient education, planning, technique and follow-up helps minimize complications.

Revision breast surgery is broad, ranging from minor scar or shape adjustments to full reshaping and resizing. After augmentation, implant revision may be needed for healing problems, infection, shape, symmetry or scars. Later changes from pregnancy, breastfeeding, menopause, weight gain or loss, or breast ageing can also alter results. Implant failure or rupture, capsular contracture and recurrent ptosis are further indications; a lift or reduction may become part of the secondary procedure. A second surgery to improve symmetry after reconstruction or to transfer more fat is often planned as a second stage rather than a revision. All potential risks are more likely in secondary procedures.

For mild to moderate size differences, generally less than 90 to 120 cc, carefully selected bilateral asymmetric implants may be more appropriate than a single implant, which can elevate the nipple and worsen appearance. Breast size and other asymmetries are interdependent, and significant deformity may need additional intervention. Adjustable implants can allow volume changes after surgery. In one study of 402 patients, similar-volume implants plus glandular resection from the larger breast gave good results; 72% needed no further asymmetry management, while 28% needed additional correction for ptosis or fold differences. The final surgical plan depends on your anatomy, goals and expectations.

Capsular contracture is the most common complication associated with breast implant placement and can cause hardening, discomfort, pain and poor aesthetic outcomes. Revision may involve releasing or removing scar tissue around the implant, changing the implant pocket, exchanging the implant, or using acellular dermis, but these approaches are not always able to prevent recurrence. Long-standing contracture, subglandular placement and oversized implants may be associated with more soft-tissue thinning and atrophy. In one reported series of 23 patients with Baker III or IV contracture after subglandular augmentation, revision indications also included ptosis, malposition and dissatisfaction. The incidence is highly variable by implant type and surgical technique.

Displacement can happen from pocket dissection differences, early excessive movement, sleeping position, or implant rotation, especially with smooth gel implants that do not adhere as textured implants do. Anatomic implants may rotate if a seroma or double capsule develops. Mild displacement may be managed with a modeling bra, elastic bands or massage. More severe or long-term displacement usually needs reoperation to reshape the pocket by releasing or tightening the scar capsule around the implant; in some cases, additional support may be considered. Revision is secondary surgery, so risks and need for further procedures are higher than after a first augmentation. Careful diagnosis and planning matter.

Bottoming out means the implant sits too low. A double bubble means the implant and breast tissue or fold create two contours. Causes can include inadequate release of the lower breast fold, breast tissue drooping over the implant, and muscle adhesions after dual-plane release. Revision may involve moving the implant to a different pocket, tightening the capsule, lifting breast tissue or releasing muscle attachments, but correction can be difficult and some deformity may remain. The plan depends on implant position, fold anatomy and skin support. Subpectoral implants can contribute to animation-related double bubble, and moving the implant to a pocket above the muscle may be considered. Overdissection or tight folds can also play a role, so thorough assessment is needed.

In revision breast augmentation, one approach is to remove the original scar and create a new wound rather than cut through a mature scar and repair it. If the first surgery used an armpit or areola incision, a new incision under the breast may be recommended in some cases to reduce the risk of a visible soft-tissue deformity. The original incision site, implant pocket, capsule work and desired size change all influence planning. Careful technique, bleeding control, biofilm mitigation and infection-prevention steps are important to prevent complications, and accurate sizing helps avoid implant flip-over. The surgeon also carefully checks pocket dimensions and implant details before choosing the replacement size.

Implants are not lifelong devices and usually need removal with or without replacement after about 10 to 15 years. Reasons include implant problems such as malposition, capsular contracture, rupture, discomfort, uncommon capsule cancers, or breast implant illness symptoms; breast changes; or a change of mind. Risks include bleeding, infection, seroma, wound-healing problems, clots, altered nipple sensation, asymmetry, recurrent lax tissue, tissue loss and poor scarring. If implants are replaced, implant risks such as capsular contracture, malposition, rupture, uncommon capsule cancers, or breast implant illness symptoms are also considerations. Risks can be reduced by healthy steady weight, planning around pregnancies and lifestyle, avoiding nicotine, optimizing conditions such as diabetes, and following aftercare advice.

The exact time depends on the operation's scope. Removal alone may be shorter; replacement or additional breast procedures take longer. General anaesthesia is most common, though implant removal alone can sometimes be done under local anaesthesia with sedation if no other procedures are planned. It is usually day surgery unless combined with procedures requiring an overnight stay. Implants are not lifelong devices; their average lifespan is 10 to 15 years, so future surgery may be needed. Some implants do not last quite so long, while others last many years longer without problems. Aftercare also depends on whether removal is alone or combined with other breast procedures.

Revision may involve changing the implant, its position, removing scar tissue around it, or lifting the breast; healing is prolonged compared with first surgery. Final shape and implant position can take time, and one source suggests waiting at least a year before judging revision successful. Complications are similar to first cases, but nipple-area blood-supply risk rises with complexity. You will need a support bra and scar care; results are affected by weight and hormonal changes, and implants average 10 to 15 years. Capsular contracture can recur even years later. One study of pocket conversion reported hospital stay averaging 4.5 days and sport limited for 4 weeks.

Implants are not lifetime devices; annual monitoring is advised, and they may need replacement or removal within 10 to 15 years, though normal follow-up may allow them to stay longer. If a capsule problem, significant rupture or capsular contracture is found, capsulectomy may be needed. If breast tissue sags after removal or a smaller implant, a mastopexy may be performed too. The plan depends on your tissue, goals and examination. Replacement can be combined with other breast procedures, and the surgeon will assess implant size, shape, position and tissue quality before deciding. Capsule removal is considered when scar tissue around the implant causes problems. Recovery and follow-up also depend on whether a lift or fat transfer is included.

Implant removal alone may leave loose skin and loss of upper fullness, especially after pregnancy, breastfeeding, weight change or aging. Implants can be simply removed or combined with other breast procedures. You may wish to have implants replaced or fat transfer instead. A mastopexy reshapes and lifts breast tissue; auto-augmentation can use your own tissue to fill space after implant removal, producing a smaller breast with youthful contours. If sagging is severe, augmentation alone does not correct it, so a lift may be needed. Whether procedures are combined or staged depends on your tissue, goals and safety. If capsular contracture or significant rupture is detected, capsulectomy may be needed.

Breast augmentation and mastopexy are generally considered cosmetic, so insurers often exclude them unless there is a functional or reconstructive indication. Exceptions can include symmetry after breast cancer reconstruction, or significant congenital asymmetry or deformity with documented distress. Many carriers also have policy riders excluding complications from cosmetic procedures. Your insurer’s criteria, documentation requirements and prior approval process will determine any possible coverage for implant removal or revision surgery. Dr. Vishal Purohit can review your situation during consultation. The clinic team can help with clinical documentation and pre-authorisation or reimbursement paperwork, and coordinate eligible hospital cashless claims subject to insurer approval, but cannot guarantee coverage or cashless eligibility.